Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer

被引：0
|
作者：
Silvia Cantara
Eugenio Bertelli
Rossella Occhini
Marì Regoli
Lucia Brilli
Furio Pacini
Maria Grazia Castagna
Paolo Toti
机构：
[1] University of Siena,Department of Medical, Surgical and Neurological Sciences
[2] University of Siena,Department of Molecular and Developmental Medicine
[3] Arezzo Hospital,Unit of Pathology
[4] University of Siena,undefined
来源：
Endocrine | 2019年 / 64卷
关键词：
PD-L1; PD-1; Anaplastic thyroid cancer; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：122 / 129
页数：7
相关论文
共 50 条
  • [1] Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer
    Cantara, Silvia
    Bertelli, Eugenio
    Occhini, Rossella
    Regoli, Mari
    Brilli, Lucia
    Pacini, Furio
    Castagna, Maria Grazia
    Toti, Paolo
    ENDOCRINE, 2019, 64 (01) : 122 - 129
  • [2] Recent advances in atezolizumab-based programmed death-ligand 1 (PD-L1) blockade therapy for breast cancer
    Ameri, Ali
    Tavakoli-Far, Bahareh
    Rostami, Maryam
    Kiasari, Bahman Abedi
    Sakhaei, Delaram
    Ahmed, Omar Saad
    Forouzani, Fatemeh
    Fazli, Yasaman
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [3] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Lathika, Aryakrishna S.
    Lakshmi, S.
    Ramdas, Preethi T.
    Kumar, Aswin
    Mathews, Susan
    Joseph, John
    Mathew, Aleyamma
    James, Francis V.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [4] The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy
    Zhang, Lifang
    Zhao, Yu
    Tu, Quanmei
    Xue, Xiangyang
    Zhu, Xueqiong
    Zhao, Kong-Nan
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (05) : 893 - 909
  • [5] Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
    Nunez Abad, Martin
    Calabuig-Farinas, Silvia
    Lobo de Mena, Miriam
    Torres-Martinez, Susana
    Garcia Gonzalez, Clara
    Garcia Garcia, Jose Angel
    Iranzo Gonzalez-Cruz, Vega
    Camps Herrero, Carlos
    CANCERS, 2022, 14 (02)
  • [6] Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
    Botti, Gerardo
    Scognamiglio, Giosue
    Marra, Laura
    Pizzolorusso, Antonio
    Di Bonito, Maurizio
    De Cecio, Rossella
    Cantile, Monica
    De Chiara, Annarosaria
    JOURNAL OF CANCER, 2017, 8 (16): : 3166 - 3172
  • [7] Fragment-based screening of programmed death ligand 1 (PD-L1)
    Perry, Evan
    Mills, Jonathan J.
    Zhao, Bin
    Wang, Feng
    Sun, Qi
    Christov, Plamen P.
    Tarr, James C.
    Rietz, Tyson A.
    Olejniczak, Edward T.
    Lee, Taekyu
    Fesik, Stephen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (06) : 786 - 790
  • [8] Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms
    Giunchi, Francesca
    Gevaert, Thomas
    Scarpelli, Marina
    Fiorentino, Michelangelo
    CURRENT DRUG TARGETS, 2020, 21 (13) : 1286 - 1292
  • [9] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
    Govindarajan, Rangaswamy
    Gujja, Swetha
    Siegel, Eric R.
    Batra, Anu
    Saeed, Anwaar
    Lai, Keith
    James, Jennifer D.
    Fogel, Bradley J.
    Williamson, Stephen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 638 - 642
  • [10] Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)
    Michikawa, Chieko
    Gopalakrishnan, Vancheswaran
    Harrandah, Amani M.
    Karpinets, Tatiana, V
    Garg, Rekha Rani
    Chu, Randy A.
    Park, Yuk Pheel
    Chukkapallia, Sasanka S.
    Yadlapalli, Nikhita
    Erikson-Carter, Kelly C.
    Gleber-Netto, Frederico Omar
    Sayour, Elias
    Progulske-Fox, Ann
    Chan, Edward K. L.
    Wu, Xiaogan
    Zhang, Jianhua
    Jobin, Christian
    Wargo, Jennifer A.
    Pickering, Curtis R.
    Myers, Jeffrey N.
    Silver, Natalie
    NEOPLASIA, 2022, 31
12345